China National Accord Medicines Corporation Ltd. Share Price
Equities
000028
CNE0000009N6
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.11 CNY | -2.42% | -0.31% | +21.11% |
Sales 2024 * | 80.71B 11.14B 929B | Sales 2025 * | 85.88B 11.85B 988B | Capitalization | 18B 2.48B 207B |
---|---|---|---|---|---|
Net income 2024 * | 1.78B 245M 20.44B | Net income 2025 * | 1.89B 261M 21.77B | EV / Sales 2024 * | 0.25 x |
Net Debt 2024 * | 2.48B 342M 28.55B | Net Debt 2025 * | 3.35B 463M 38.57B | EV / Sales 2025 * | 0.25 x |
P/E ratio 2024 * |
11
x | P/E ratio 2025 * |
10.3
x | Employees | 39,449 |
Yield 2024 * |
2.16% | Yield 2025 * |
2.35% | Free-Float | 42.7% |
1 day | -2.42% | ||
1 week | -0.31% | ||
Current month | +14.29% | ||
1 month | +17.31% | ||
3 months | +16.84% | ||
6 months | +22.21% | ||
Current year | +21.11% |
Managers | Title | Age | Since |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 01/08/01 |
Guo Lin Gu
DFI | Director of Finance/CFO | 49 | 28/20/28 |
Min Lin
CHM | Chairman | 59 | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 01/08/01 |
Min Lin
CHM | Chairman | 59 | 01/08/01 |
Yi Jian Wu
BRD | Director/Board Member | 54 | 13/20/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 35.11 | -2.42% | 6,372,578 |
25/24/25 | 35.98 | +2.95% | 6,057,706 |
24/24/24 | 34.95 | +2.52% | 6,009,046 |
23/24/23 | 34.09 | -4.59% | 7,990,845 |
22/24/22 | 35.73 | +1.45% | 7,113,052 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.11% | 2.48B | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- 000028 Stock